(Q34294750)

1 August 2017

title

Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders (English)

1 reference

1 August 2017

1 reference

1 reference

Zacharoula Konsoula

1

1 reference

1 August 2017

Frank A Barile

series ordinal

2

1 reference

1 August 2017

publication date

10 August 2012

1 reference

Journal of Pharmacological and Toxicological Methods

1 August 2017

published in

1 reference

1 August 2017

volume

66

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

215-220

1 reference

Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders.

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Rational development of histone deacetylase inhibitors as anticancer agents: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

The GDNF family: signalling, biological functions and therapeutic value

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Parkinson's disease: mechanisms and models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histone deacetylase 6 interacts with the microtubule-associated protein tau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histone Deacetylase Inhibition by Sodium Butyrate Chemotherapy Ameliorates the Neurodegenerative Phenotype in Huntington's Disease Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Recovery of learning and memory is associated with chromatin remodelling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

A novel pathway regulates memory and plasticity via SIRT1 and miR-134

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

HDAC2 negatively regulates memory formation and synaptic plasticity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Regional and cellular gene expression changes in human Huntington's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Mechanisms for the control of gene activity during development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Animal models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Early environmental origins of neurodegenerative disease in later life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histone deacetylation in epigenetics: an attractive target for anticancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Pathways towards and away from Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histone deacetylase inhibitors reduce polyglutamine toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

HDAC3 and the molecular brake pad hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Altered histone acetylation is associated with age-dependent memory impairment in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Tau--an inhibitor of deacetylase HDAC6 function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Epigenetic inheritance during the cell cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histone deacetylase inhibitors in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Occupational risk factors in Alzheimer's disease: a review assessing the quality of published epidemiological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Combinatorial chromatin modifications and memory storage: a code for memory?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

HDAC6 modulates cell motility by altering the acetylation level of cortactin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2012.08.001

10.1016/J.VASCN.2012.08.001

7 January 2021

Identifiers

DOI

1 reference

1 August 2017

1 reference